← John Polomny hub  ·  Research hub  ·  Research library

Uranium's term price hits an all-time high — "bull market intact"

A macro-heavy 4th-of-July weekly: the liquidity/Cantillon lens on record-high valuations, "own hard assets you can't print," a new starter ARKG biotech position, the Strait-of-Hormuz oil "sugar rush," the uranium term price at $95.50/lb (an all-time high) with supply shutdowns from a sulfuric-acid shortage, Friedland's copper math, Latin America's right-wing rerating, food inflation from a super El Niño, and a new "cannibal" serial-buyback name.
2026-JUL-04 · AIA Weekly Market Update (YouTube) · John Polomny · ~33 min · ▶ Watch · transcript · actionable insights
In one line: money-printing keeps a floor under record valuations (Raoul Paul's ~97% liquidity/NASDAQ correlation; the Cantillon effect), so "own hard assets they can't create by fiat" — oil, gold, uranium. Uranium's June term price hit an all-time-high $95.50/lb with conversion and enrichment also at ATHs, while Orano (McClean Lake), Cameco (Cigar Lake) and Lotus (Kayelekera) all shut on a sulfuric-acid shortage traced back to the Gulf. He adds a starter ARKG biotech position on a bottoming chart (+73% YoY fund flow), likes Latin America on the left→right political rerating (Ecopetrol board purge; EC / GPRK / PXT as ways to watch it), warns of higher food prices into 2027 (super El Niño + fewest US wheat acres in 149 years), and teases a new "cannibal" serial-buyback name (Singleton/Teledyne, AZO as the exemplar).

1. Stocks & names mentioned

TickerNameResearchViewWhat he saidAt
ARKGARK Genomic Revolution ETFQT · SA · STKPositive"I've taken a position in the ARKG biotech fund." A new starter position taken because biotech indices have "either bottomed or broken higher on the charts" after ~7–8 years out of favor, with global biotech fund flow up 73% year-over-year; he isn't a biotech expert, so he's using the ETF to get exposure to a turning sector while AI-driven drug discovery could spill over.05:52
SRUUFSprott Physical Uranium Trust (U.UN)SA · STKPositiveThe June long-term (term) uranium price came in at $95.50/lb — "the highest term price ever" — and conversion and enrichment prices are also at all-time highs. "We are in a bull market that will continue until the necessary investments are made." Physical uranium remains a core holding and the bull thesis is reaffirmed.15:48
CCJCamecoQT · SA · STK · FAPositiveNamed in the uranium supply-woes item: "Cameco shuts down the world's largest uranium mine at Cigar Lake" — one of three simultaneous shutdowns (with Orano and Lotus) caused by sulfuric-acid shortages. Cited as bullish-supply context in a market he says is undersupplied and grinding higher.16:17
ECEcopetrolQT · SA · STK · FANeutralColombia's new right-wing president has decreed he will replace the board and management of state-controlled Ecopetrol, whose prior leadership stifled oil & gas investment until reserves declined. "Is it a buy? I don't know." Flagged as a regime-change rerating candidate to watch, not a call.24:47
GPRKGeoParkQT · SA · STK · FANeutralNamed as an independent Colombian oil operator "you might want to look at" alongside Ecopetrol's board change — a private E&P that has partnered with Ecopetrol and could benefit from a more resource-friendly government. A watch idea, not a recommendation.25:56
PXTParex Resources (TSX)SA · STK · FANeutral"Parex is another one that you might want to look at." A second independent Colombian oil operator named with GeoPark — independents that have partnered with Ecopetrol and could re-rate if the new government reopens exploration. A watch idea only.25:56
AZOAutoZoneQT · SA · STK · FANeutralCited as the exemplar "cannibal": "look at the performance of AutoZone over the last 20 or 30 years… it has consistently been cannibalizing its outstanding stock and buying back stock over time," which "helped propel the shares" and drive market outperformance. An illustration of the serial-buyback compounding he's studying — not a buy call.32:56

Stances reflect this weekly's framing only. A macro-heavy update: EC / GPRK / PXT are LatAm regime-change watch ideas (not stated holdings); AZO is an illustrative buyback exemplar. The "drug company" that is one of the portfolio's best performers, the "large copper miner in Africa" selling ~$1M/day of sulfuric acid, and the new "cannibal" permanent-capital vehicle (a Saudi family-office-backed name) were left unnamed and are intentionally not tickerized.

2. Talking points

00:56 — Record valuations & the liquidity lens ("Project Zimbabwe")

02:09 — Money-printing is the floor; the Cantillon effect

04:12 — "Own hard assets you can't print"

05:52 — A starter biotech position (ARKG)

09:06 — Out-of-favor US regional/community banks

09:27 — The Strait of Hormuz "sugar rush"

11:14 — "Kabuki theater" — not a lasting peace

14:04 — China's demand is offline (for now)

15:48 — Uranium term price at an all-time high ($95.50)

16:17 — Three uranium shutdowns on a sulfuric-acid shortage

17:40 — The sulfuric-acid chain (Gulf → uranium & fertilizer)

19:23 — Conversion & enrichment also at all-time highs

20:58 — Friedland's copper math

22:05 — Latin America's right-wing rerating

26:46 — LatAm cheap vs 20 years of US outperformance

28:40 — Super El Niño & the fewest wheat acres in 149 years

30:34 — A new "cannibal" for the newsletter (Singleton / Teledyne / AutoZone)

3. In plain English

ARKG — ARK Genomic Revolution ETF Positive

ARKG is a fund that owns a basket of biotech and gene-medicine companies. The whole sector has been unloved for roughly seven or eight years, so the stocks are cheap — and Polomny says the charts have finally stopped falling and started turning up, with money flowing back into biotech (fund inflows up 73% versus a year ago). He freely admits he's no expert in individual drug stocks, which is exactly why he buys the ETF: it's a low-effort "starter" way to own the sector's recovery without having to pick the one winning drug. His extra angle is that AI could speed up drug discovery, giving biotech a fresh tailwind. A small position in a bombed-out, turning sector — a "taste," not a big bet.

SRUUF — Sprott Physical Uranium Trust Positive

This trust simply holds physical uranium in storage, so its price tracks the uranium price rather than any single mining company. Polomny's point is that the long-term contract price utilities pay for uranium just hit an all-time high of $95.50 a pound, and the prices for turning that uranium into reactor fuel (conversion and enrichment) are at records too. Demand keeps rising as new reactors switch on, but new mines take many years and billions of dollars that haven't been spent yet — so supply can't catch up. That gap is why he stays long uranium: "a bull market that will continue until the necessary investments are made."

CCJ — Cameco Positive

Cameco is one of the world's biggest uranium miners. Here it comes up as a supply story rather than a stock pitch: Cameco just shut its Cigar Lake mine (the world's largest) at the same time France's Orano shut the world's largest processing mill and a mine in Malawi closed — all three tripped up by a shortage of sulfuric acid, a basic chemical needed to process ore. When the biggest producers go offline at once in a market that's already short of uranium, it tightens supply further and supports the whole uranium-bull thesis Polomny is playing.

EC — Ecopetrol Neutral

Ecopetrol is Colombia's government-controlled oil company. The outgoing left-wing government discouraged new oil and gas drilling to the point that Colombia's oil reserves have been shrinking. Now a new right-wing president says he'll replace Ecopetrol's board and management with people keen to develop the country's resources. Polomny's interest is the pattern — when a country swings from left to right, its beaten-down stock market can re-rate higher — but he's explicitly not making a call on the stock itself: "Is it a buy? I don't know." A situation to watch, not a recommendation.

GPRK — GeoPark Neutral

GeoPark is an independent oil producer that operates in Colombia and has partnered with Ecopetrol. Polomny names it as one of the smaller, privately run operators that could benefit if Colombia's new government reopens the country to oil and gas investment — you get exposure to the same political turnaround without owning the state-run giant. He offers it as something "you might want to look at," not a buy call.

PXT — Parex Resources Neutral

Parex Resources is another independent oil company focused on Colombia (listed in Canada). Like GeoPark, it partners with Ecopetrol and would stand to gain if a more resource-friendly Colombian government revives exploration and production. Polomny lists it alongside GeoPark as a name to research if you want to play Colombia's political shift through the nimbler independents rather than the state company. A watch idea only.

AZO — AutoZone Neutral

AutoZone sells car parts, but Polomny brings it up purely as a textbook "cannibal." A cannibal is a company that spends its cash steadily buying back and cancelling its own shares. Because the profits are then divided among fewer and fewer shares, each remaining share is worth more over time — even if the business itself only grows modestly. AutoZone has done this consistently for 20–30 years, which he says helped drive its stock's long outperformance. He uses it as the illustration of the serial-buyback strategy behind a new name he's adding to his newsletter — it's an example of the method, not a buy recommendation.


Built from the public YouTube weekly (see the clickable transcript) — stances and quotes are Polomny's own wording. For personal study — not investment advice.